相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice
Xia Cao et al.
HYPERTENSION RESEARCH (2014)
Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: Possible role of SOCS-1 in reducing pro-inflammatory responses
Dario D. Lofrumento et al.
INNATE IMMUNITY (2014)
In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery
S. Jose et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Sirt1 Activation Ameliorates Renal Fibrosis by Inhibiting the TGF-β/Smad3 Pathway
Xin-Zhong Huang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Resveratrol attenuates hypoxia/reoxygenation-induced Ca2+ overload by inhibiting the Wnt5a/Frizzled-2 pathway in rat H9c2 cells
Xiang Wu et al.
MOLECULAR MEDICINE REPORTS (2014)
Resveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice
Renzo Mancuso et al.
NEUROTHERAPEUTICS (2014)
Resveratrol Protects DAergic PC12 Cells from High Glucose-Induced Oxidative Stress and Apoptosis: Effect on p53 and GRP75 Localization
Justine Renaud et al.
NEUROTOXICITY RESEARCH (2014)
Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo
Sang Hyuk Hong et al.
Pharmacological Reports (2014)
Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction
Jin Liang et al.
RENAL FAILURE (2014)
Resveratrol Ameliorates Motor Neuron Degeneration and Improves Survival in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Lin Song et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Resveratrol Reverses Remodeling in Hearts with Large, Old Myocardial Infarctions through Enhanced Autophagy-Activating AMP Kinase Pathway
Hiromitsu Kanamori et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men
Satya Dash et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
Rakesh Popat et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression
P. Liu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Joao Tomé-Carneiro et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
High-Dose Resveratrol Supplementation in Obese Men An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
Morten M. Poulsen et al.
DIABETES (2013)
Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells
Hongmei Luo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4′-tri-O-acetylresveratrol in rats
Li Liang et al.
PHYTOMEDICINE (2013)
Pulmonary Metabolism of Resveratrol: In Vitro and In Vivo Evidence
Satish Sharan et al.
DRUG METABOLISM AND DISPOSITION (2013)
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
S. Gomez-Zorita et al.
BRITISH JOURNAL OF NUTRITION (2012)
Resveratrol Helps Recovery from Fatty Liver and Protects against Hepatocellular Carcinoma Induced by Hepatitis B Virus X Protein in a Mouse Model
Hsiu-Ching Lin et al.
CANCER PREVENTION RESEARCH (2012)
Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance
Jun Yoshino et al.
CELL METABOLISM (2012)
SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
Nathan L. Price et al.
CELL METABOLISM (2012)
Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
A. R. Neves et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Resveratrol promotes neurotrophic factor release from astroglia
Feng Zhang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
Resveratrol mitigates lipopolysaccharide- and Aß-mediated microglial inflammation by inhibiting the TLR4/NF-?B/STAT signaling cascade
Hemachander Capiralla et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Analytical method development for synthesized conjugated metabolites of trans-resveratrol, and application to pharmacokinetic studies
Otito F. Iwuchukwu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2012)
Challenges of Translating Basic Research Into Therapeutics: Resveratrol as an Example
James M. Smoliga et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
Jill P. Crandall et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats
Lina Wu et al.
MOLECULAR BIOLOGY REPORTS (2012)
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Jayesh Kumar Bhatt et al.
NUTRITION RESEARCH (2012)
Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease
K. Magyar et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2012)
Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling
P. Palsamy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
Pal Brasnyo et al.
BRITISH JOURNAL OF NUTRITION (2011)
Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
Izet M. Kapetanovic et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases-Safety, Pharmacokinetics, and Pharmacodynamics
Lynne M. Howells et al.
CANCER PREVENTION RESEARCH (2011)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats
Siddhartha R. Bhatt et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats
Yanchun Wang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Resveratrol Improves Insulin Resistance Hyperglycemia and Hepatosteatosis But Not Hypertriglyceridemia, Inflammation, and Life Span in a Mouse Model for Werner Syndrome
Adam Labbe et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
Enhancing the bioavailability of resveratrol by combining it with piperine
Jeremy J. Johnson et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Resveratrol Inhibits Growth of Orthotopic Pancreatic Tumors through Activation of FOXO Transcription Factors
Sanjit K. Roy et al.
PLOS ONE (2011)
Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure
Stephanie Rimbaud et al.
PLOS ONE (2011)
Resveratrol Attenuates Renal Hypertrophy in Early-Stage Diabetes by Activating AMPK
Da-Fa Ding et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Anticancer Activity and Molecular Mechanism of Resveratrol-Bovine Serum Albumin Nanoparticles on Subcutaneously Implanted Human Primary Ovarian Carcinoma Cells in Nude Mice
Liyuan Guo et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Resveratrol Suppresses Oxidative Stress and Inflammatory Response in Diethylnitrosamine-Initiated Rat Hepatocarcinogenesis
Anupam Bishayee et al.
CANCER PREVENTION RESEARCH (2010)
Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
H-H. Sherry Chow et al.
CANCER PREVENTION RESEARCH (2010)
Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase
Naomi Oi et al.
CANCER RESEARCH (2010)
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria A. Brown et al.
CANCER RESEARCH (2010)
Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects
Charles la Porte et al.
CLINICAL PHARMACOKINETICS (2010)
AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol
Jee-Hyun Um et al.
DIABETES (2010)
Characterization of trans-Resveratrol-Loaded Lipid-Core Nanocapsules and Tissue Distribution Studies in Rats
Rudimar L. Frozza et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2010)
Resveratrol bioavailability and toxicity in humans
Charles-Henry Cottart et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Sang-Won Min et al.
NEURON (2010)
Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer
Randall F Holcombe et al.
Cancer Management and Research (2010)
Protective Effects of Resveratrol and Quercetin Against MPP+ -Induced Oxidative Stress Act by Modulating Markers of Apoptotic Death in Dopaminergic Neurons
Julie Bournival et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2009)
Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1
Vernon W. Dolinsky et al.
CIRCULATION (2009)
Pharmacokinetics of Trans-resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects
Teresa Nunes et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice
Gyeong-Min Do et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity
Yu-Min Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet
Jiyun Ahn et al.
JOURNAL OF HEPATOLOGY (2008)
被撤回的出版物: Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis (Retracted article. See vol. 233, 2019)
Neetu Kalra et al.
LIFE SCIENCES (2008)
The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol
Surajit Das et al.
PHARMACEUTICAL RESEARCH (2008)
Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP
Ming Y. Shen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Resveratrol - From basic science to the clinic
Valeria Cucciolla et al.
CELL CYCLE (2007)
Resveratrol suppresses prostate cancer progression in transgenic mice
Curt E. Harper et al.
CARCINOGENESIS (2007)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice
Giuseppe Danilo Norata et al.
ATHEROSCLEROSIS (2007)
Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities
Eun-Ok Lee et al.
CARCINOGENESIS (2006)
Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFκB
Samarjit Das et al.
FREE RADICAL RESEARCH (2006)
Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance
Gyorgyi Stef et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
S Garvin et al.
CANCER LETTERS (2006)
Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats
S Sharma et al.
PHARMACOLOGY (2006)
Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides
P Marambaud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effect of Resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
M Provinciali et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Substrate-specific activation of sirtuins by resveratrol
M Kaeberlein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice
Hai-Bo Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin
MH Aziz et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2005)
Resveratrol protects myocardial ischemia-reperfusion injury through both no-dependent and no-independent mechanisms
LM Hung et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases
MT Borra et al.
BIOCHEMISTRY (2004)
High absorption but very low bioavailability of oral resveratrol in humans
T Walle et al.
DRUG METABOLISM AND DISPOSITION (2004)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene
A Revel et al.
JOURNAL OF APPLIED TOXICOLOGY (2003)
Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model
JF Marier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
A comparison of the anticarcinogenic properties of four red wine polyphenols
GJ Soleas et al.
CLINICAL BIOCHEMISTRY (2002)
Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis
Y Schneider et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2001)
Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver
C De Santi et al.
XENOBIOTICA (2000)
Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression
L Tessitore et al.
CARCINOGENESIS (2000)
分享论文
